Factor X Polyclonal Antibody, PE-Cy5.5 Conjugated, PE/Cy5.5, Rabbit

Artikelnummer: BSS-BS-9501R-PE-CY5.5
Artikelname: Factor X Polyclonal Antibody, PE-Cy5.5 Conjugated, PE/Cy5.5, Rabbit
Artikelnummer: BSS-BS-9501R-PE-CY5.5
Hersteller Artikelnummer: bs-9501R-PE-Cy5.5
Alternativnummer: BSS-BS-9501R-PE-CY5.5-100
Hersteller: Bioss
Wirt: Rabbit
Kategorie: Antikörper
Applikation: WB
Spezies Reaktivität: Mouse, Rat
Konjugation: PE/Cy5.5
Alternative Synonym: Activated factor Xa heavy chain, Coagulation factor, Coagulation factor X, EC 3.4.21.6, F10 antibody FA10_HUMAN, Factor Xa, FX, FXA, OTTHUMP00000018735, Prothrombinase, Stuart factor, Stuart Prower factor, Stuart-Prower factor, Coagulation factor X, Factor X heavy chain.
Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (Prothrombin and Factors X, IX, V and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble Fibrin clots and the promotion of platelet aggregation. Coagulation Factor X (Stuart Prower factor, FX, F10) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor. The mature form of Factor X (Factor X A) is generated by Factor IX A- or Factor VII A-mediated cleavage at the tripeptide sequence, Arg-Lys-Arg, to yield a disulfide linked dimer. Together with the cofactor Factor V A and Ca2+ on the surface of platelets or endothelial cells, Factor X A coordinates as part of the prothrombinase complex, which mediates proteolysis of Prothrombin into active Thrombin. Mutations at the Factor X locus resulting in Factor X deficiencies can contribute to hemorrhagic diathesis.
Klonalität: Polyclonal
Konzentration: 1ug/ul
NCBI: 2159
Puffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Quelle: KLH conjugated synthetic peptide derived from human Activated factor Xa heavy chain
Target-Kategorie: Factor X
Application Verdünnung: WB(1:300-5000)